Morning Analyst Calls Briefing for Tuesday, November 1, 2022 

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Morning Analyst Calls Briefing for Tuesday, November 1, 2022 

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> AnaptysBio (ANAB) upgraded to Buy from Neutral at Guggenheim; tgt $44

> Exxon Mobil (XOM) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $115

> Komatsu (KMTUY) upgraded to Neutral from Sell at Goldman

> Lennox Int’l (LII) upgraded to Neutral from Underweight at JP Morgan; tgt $226

Downgrades:

> Emerson (EMR) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $96

> Steven Madden (SHOO) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $29

> TuSimple Holdings (TSP) downgraded to Perform from Outperform at Oppenheimer

> TuSimple Holdings (TSP) downgraded to Underweight from Overweight at JP Morgan

> Varonis Systems (VRNS) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $20

Others:

> ACADIA Pharmaceuticals (ACAD) initiated with a Hold at Loop Capital; tgt $17

> atai Life Sciences N.V. (ATAI) initiated with a Buy at Loop Capital; tgt $18

> ATS Automation (ATSAF) assumed with an Outperform at RBC Capital Mkts

> Axsome Therapeutics (AXSM) initiated with a Buy at Loop Capital; tgt $95

> Cerevel Therapeutics (CERE) initiated with a Buy at Loop Capital; tgt $40

> Chemours (CC) initiated with an Underperform at Credit Suisse; tgt $24

> COMPASS Pathways (CMPS) initiated with a Buy at Loop Capital; tgt $34

> Evolent Health (EVH) initiated with a Hold at Truist; tgt $33

> Horizon Pharma (HZNP) initiated with a Neutral at H.C. Wainwright; tgt $74

> Karuna Therapeutics (KRTX) initiated with a Buy at Loop Capital; tgt $288

> Kone Oyj (KNYJY) initiated with a Hold at Deutsche Bank

> Legend Biotech (LEGN) initiated with an Outperform at Cowen

> NorthWestern (NWE) initiated with a Neutral at JP Morgan; tgt $55

> OptimizeRx (OPRX) initiated with a Buy at Stifel; tgt $19

> Rocket Pharmaceuticals (RCKT) initiated with a Buy at BTIG Research; tgt $35

> SAGE Therapeutics (SAGE) initiated with a Hold at Loop Capital; tgt $41

> Schindler (SHLAF) initiated with a Buy at Deutsche Bank

> Sumitomo Mitsui (SMFG) resumed with a Buy at Nomura

> Tronox (TROX) initiated with an Underperform at Credit Suisse; tgt $10

> Under Armour (UAA) resumed with a Neutral at BofA Securities; tgt $8

Research calls posted earlier this morning are available here.  

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618